|
Kalen et al.: Age-related changes in the lipid compositions of rat and human tissues. Lipids 24: 579–584, 1989
Golden, T. R. et al.: Mitochondrial DNA mutations, oxidative stress and aging. Mech. Aging Dev. 122: 1577-1589, 2001
Blasi, M. A. et al.: Does coenzyme Q10 play a role in opposing oxidative stress in patients with age-related macular degeneration? Ophtalmologica 215: 51-54, 2001
Xia, L. et al.: The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. J. Biol.
Chem. 24: 2141-2146, 2003
Calabrese, V. et al.: Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26:
739-764, 2001
Mortensen, S. A. et al.: Langzeitbehandlung mit Coenzym Q10: ein wichtiger Fortschritt in der Behandlung therapieresistenter Herzerkrankungen. Drugs Exp. Clin.
Res. 11: 581, 1985
Kamikaura, T. et al.: Wirkungen von Coenzym Q10 auf die Ausdauer bei chronisch stabiler Angina pectoris. Am. J. Card. 56: 242, 1985
Langsjoen, P. H. et al.: Eine sechsjährige klinische Untersuchung der Behandlung von Cardiomyopathien mit Coenzym Q10. Int. Res. Tiss. React. 12: 169, 1990
Crane, F. L.: Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20: 591-598, 2001
Hansen, I. L. et al.: Bioenergetics in clinical medicine IX. Gingival and leukocytic deficiencies of coenzyme Q10 in patients with periodontal disease. Res. Commun.
Chem. Pathol. Pharmacol. Aug; 14 (4): 729-38, 1976
Döll, M.: Peridontale Erkrankungen – ist eine Supplementierung mit Coenzym Q10 sinnvoll? J. Orthomol. Med., 7. Jahrgang, Heft 1, 1999
Folkers, K., Watanabe, T.: Bioenergetics in clinical medicine-X. Survey of the adjunctive use of coenzyme Q with oral therapy in treating periodontal disease. J. Med. 8:
333-48, 1977
Gian Paolo Littarru (1994) Energy and Defense. Facts and
perspectives on CoenzymeQ10 in biology and medicine. Casa
Editrice Scientifica Internazionale, pp 1-91.
Crane F.L., Hatefi Y., Lester R.I., Widmer C. (1957)
Isolation of a quinone from beef heart mitochondria. In:
Biochimica et Biophys. Acta, vol. 25, pp 220-221.
Morton R.A., Wilson G.M., Lowe J.S., Leat W.M.F. (1957)
Ubiquinone. In: Chemical Industry, pp 1649.
Mellors A., Tappel A.L. (1966) Quinones and quinols as
inhibitors of lipid peroxidation. Lipids, vol. 1, pp 282-284.
Mellors A., Tappel A.L. (1966) The inhibition of
mitochondrial peroxidation by ubiquinone and ubiquinol. J.
Biol. Chem., vol. 241, pp 4353-4356.
Littarru G.P., Ho L., Folkers K. (1972) Deficiency of
Coenzyme Q10 in human heart disease. Part I and II. In:
Internat. J. Vit. Nutr. Res., 42, n. 2, 291:42, n. 3:413.
Mitchell P. (1976) Possible molecular mechanisms of the
protonmotive function of cytochrome systems. In: J.
Theoret. Biol., vol. 62, pp 327-367.
Mitchell P. (1991) The vital protonmotive role of coenzyme
Q. In: Folkers K., Littarru G.P., Yamagami T. (eds)
Biomedical and Clinical Aspects of Coenzyme Q, vol. 6,
Elsevier, Amsterdam, pp 3-10.
Mitchell P. (1988) Respiratory chain systems in theory and
practice. In: Advances in Membrane Biochemistry and
Bioenergetics, Kim C.H., et al. (eds), Plenum Press, New
York, pp 25-52.
Mitchell P. (1979) Kelin's respiratory chain concept and its
chemiosmotic consequences. In: Journal Science, vol. 206,
pp 1148-1159.
Ernster L. (1977) Facts and ideas about the function of
coenzyme Q10 in the Mitochondria. In: Folkers K.,
Yamamura Y. (eds) Biomedical and Clinical Aspects of
Coenzyme Q. Elsevier, Amsterdam, pp 15-8.
Littarru G.P., Lippa S., Oradei A., Fiorni R.M., Mazzanti L.
Metabolic and diagnostic implications of blood CoQ10 levels.
In: Biomedical and Clinical Aspects of Coenzyme Q, vol. 6
(1991) Folkers K., Yamagami T., and Littarru G. P. (eds)
Elsevier, Amsterdam, pp 167-178.
Ghirlanda G., Oradei A., Manto A., Lippa S., Uccioli L.,
Caputo S., Greco A.V., Littarru G.P. (1993) Evidence of
Plasma CoQ10 - Lowering Effect by HMG-CoA Reductase
Inhibitors: A double blind , placebo-controlled study. Clin.
Pharmocol., J. 33, 3, 226-229.
Folkers K., Langsjoen Per H.,Willis R., Richardson P., Xia
L.,Ye C., Tamagawa H. (1990) Lovastatin decreases
coenzyme Q levels in humans. Proc. Natl. Acad Sci. Vol.
87, pp.8931-8934.
Folkers K., Vadhanavikit S., Mortensen S.A. (1985)
Biochemical rationale and myocardial tissue data on the
effective therapy of cardiomyopathy with coenzyme Q10. In:
Proc. Natl. Acad. Sci., U.S.A., vol. 82(3), pp 901-904.
Mortensen S.A., Vadhanavikit S., Folkers K. (1984)
Deficiency of coenzyme Q10 in myocardial failure. In:
Drugs Exptl. Clin. Res. X(7) 497-502.
Hiasa Y., Ishida T., Maeda T., Iwanc K., Aihara T., and Mori
H. (1984) Effects of coenzyme Q10 on exercise tolerance in
patients with stable angina pectoris. In: Biomedical and
Clinical Aspects of Coenzyme Q, vol. 4 (1984) Folkers K.,
Yamamura Y., (eds) Elsevier, Amsterdam, pp 291-301.
Kamikawa T., Kobayashi A., Yamashita T., Hayashi H., and
Yamazaki N. (1985) Effects of coenzyme Q10 on exercise
tolerance in chronic stable angina pectoris. In: Am. J.
Cardiol.; 56:247-251.
Langsjoen Per.H., Vadhanavikit S., Folkers K. (1985)
Response of patients in classes III and IV of cardiomyopathy
to therapy in a blind and crossover trial with coenzyme Q10.
In: Proc. Natl. Acad. of Sci., U.S.A., vol. 82, pp 4240-4244.
Judy W.V., Hall J.H., Toth P.D., Folkers K. (1986) Double
blind-double crossover study of coenzyme Q10 in heart
failure. In: Folkers K., Yamamura Y. (eds) Biomedical and
clinical aspects of coenzyme Q, vol. 5. Elsevier,
Amsterdam, pp 315-323.
Rossi E., Lombardo A., Testa M., Lippa S., Oradei A.,
Littarru G.P., Lucente M. Coppola E., Manzoli U. Coenzyme
Q10 in ischaemic cardiopathy. In: Biomedical and Clinical
Aspects of Coenzyme Q, vol. 6 (1991) Folkers K., Yamagami
T., and Littarru G. P. (eds) Elsevier, Amsterdam, pp 321-326.
Morisco C., Trimarco B., Condorelli M. Effect of coenzyme
Q10 therapy in patients with congestive heart failure: A
long-term multicenter randomized study. In: Seventh
International Symposium on Biomedical and Clinical Aspects
of Coenzyme Q Folkers K., Mortensen S.A., Littarru G.P.,
Yamagami T., and Lenaz G. (eds) The Clinical Investigator,
(1993) 71:S 34-S 136.
Schneeberger W., Muller-Steinwachs J., Anda L.P., Fuchs
W., Zilliken F., Lyson K., Muratsu K., and Folkers K. A
clinical double blind and crossover trial with coenzyme Q10
on patients with cardiac disease. In: Biomedical and
Clinical Aspects of Coenzyme Q, vol. 5 (1986) Folkers K.,
Yamamura Y., (eds) Elsevier, Amsterdam, pp 325-333.
Schardt F., Welzel D., Schiess W., and Toda K. Effect of
coenzyme Q10 on ischaemia-induced ST-segment depression:
A double blind, placebo-controlled crossover study. In:
Biomedical and Clinical Aspects of Coenzyme Q, vol. 6
(1991) Folkers K., Yamagami T., and Littarru G. P. (eds)
Elsevier, Amsterdam, pp 385-403.
Swedberg K., Hoffman-Berg C., Rehnqvist N., Astrom H.
(1991) Coenzyme Q10 as an adjunctive in treatment of
congestive heart failure. In: 64th Scientific Sessions
American Heart Association, Abstract 774-6.
Biomedical and Clinical Aspects of Coenzyme Q. (1977)
Folkers K., Yamamura Y. (eds) Elsevier, Amsterdam, pp 1-315.
Biomedical and Clinical Aspects of Coenzyme Q, Vol. 2
(1980) Yamamura Y., Folkers K., and Ito Y. (eds) Elsevier,
Amsterdam, pp 1-456.
Biomedical and Clinical Aspects of Coenzyme Q, Vol. 3
(1981) Folkers K., Yamamura Y., (eds) Elsevier,
Amsterdam, pp 1-414.
Biomedical and Clinical Aspects of Coenzyme Q , Vol. 4
(1983) Folkers K., Yamamura Y., (eds) Elsevier,
Amsterdam, pp 1-432.
Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5
(1986) Folkers K., Yamamura Y., (eds) Elsevier,
Amsterdam, pp 1-410.
Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6
(1991) Folkers K., Yamagami T., and Littarru G. P. (eds)
Elsevier, Amsterdam, pp 1-555.
Seventh International Symposium on Biomedical and Clinical
Aspects of Coenzyme Q (1993) Folkers K., Mortensen S.A.,
Littarru G.P., Yamagami T., and Lenaz,G. (eds) The Clinical
Investigator, Supplement to Vol.71 / Issue 8, pp S51-S177.
Eighth International Symposium on Biomedical and Clinical
Aspects of Coenzyme Q (1994) Littarru G.P., Battino M. ,
Folkers K. (Eds) The Molecular Aspects of Medicine, Vol.
15 (Supplement), pp S1-S294.
Spigset O. (1994) Reduced effect of warfarin caused by
ubidecarenone. Lancet Nov 12 Vol. 344, pp. 8933.
Mortensen S.A., Vadhanavikit S., Folkers K. (1984)
Deficiency of coenzyme Q10 in myocardial failure. In: Drugs
Exptl. Clin. Res., vol. X(7), pp 497-502.
Mortensen S.A., Vadhanavikit S., Baandrup U., Folkers K.
(1985) Long term coenzyme Q10 therapy: a major advance in
the management of resistant myocardial failure. In: Drugs
Exp. Clin. Res., vol.11(8), pp 581-593.
Langsjoen P.H., Folkers K., Lyson K., Muratsu K., Lyson T.,
Langsjoen P. H. Effective and safe therapy with coenzyme
Q10 for cardiomyopathy. In: Klin. Wochenschr. (1988)
66:583-593.
Langsjoen P. H., Langsjoen, P. H., Folkers, K. (1989) Long
term efficacy and safety of coenzyme Q10 therapy for
idiopathic dilated cardiomyopathy. In: The American
Journal of Cardiology, Vol. 65, pp 521 - 523.
Mortensen S.A., Vadhanavikit S., Muratsu K., Folkers K.
(1990) Coenzyme Q10: Clinical benefits with biochemical
correlates suggesting a scientific breakthrough in the
management of chronic heart failure. In: Int. J. Tissue
React., Vol. 12 (3), pp 155-162.
Ursini T., Gambini C., Paciaroni E., and Littarru G.P.
Coenzyme Q10 treatment of heart failure in the elderly:
Preliminary results. In: Biomedical and Clinical Aspects of
Coenzyme Q, vol. 6 (1991) Folkers K., Yamagami T., and
Littarru G. P. (eds) Elsevier, Amsterdam, pp 473-480.
Poggessi L., Galanti G., Comeglio M., Toncelli L., Vinci M.
(1991) Effect of coenzyme Q10 on left ventricular function in
patients with dilative cardiomyopathy. Curr. Ther. Res.
49:878-886.
Langsjoen H.A., Langsjoen P. H., Langsjoen P. H., Willis R.,
Folkers K. (1994) Usefulness of coenzyme Q10 in clinical
cardiology, a long-term study. In: Eighth International
Symposium on Biomedical and Clinical Aspects of
Coenzyme Q, Littarru G.P., Battino M. , Folkers K. (Eds)
The Molecular Aspects of Medicine, Vol. 15 (Supplement),
pp S165-S175.
Baggio E., Gandini R., Plancher A.C., Passeri M., Carmosino
G. Italian multicenter study on safety and efficacy of
coenzyme Q10 adjunctive therapy in heart failure. In: Eighth
International Symposium on Biomedical and Clinical Aspects
of Coenzyme Q (1994) Littarru G.P., Battino M. , Folkers K.
(Eds) The Molecular Aspects of Medicine, Vol. 15
(Supplement), pp S287-S294.
Langsjoen Per H., Langsjoen Peter H., Folkers K. Isolated
diastolic dysfunction of the myocardium and its response to
CoQ10 treatment. In: Seventh International Symposium on
Biomedical and Clinical Aspects of Coenzyme Q. Folkers,
K., Mortensen S.A., Littarru G.P., Yamagami T., and Lenaz
G. (eds) The Clinical Investigator, (1993) 71:S 140-S 144.
Oda T. Recovery of the Frank-Starling mechanism by
coenzyme Q10 in patients with load-induced contractility
depression. In: Eighth International Symposium on
Biomedical and Clinical Aspects of Coenzyme Q (1994)
Littarru G.P., Battino M., Folkers K. (Eds) The Molecular
Aspects of Medicine, Vol.15 (Supplement), pp S149-S154.
Langsjoen P. H., Langsjoen P. H., Willis R., Folkers K.
(1994) Treatment of essential hypertension with coenzyme
Q10. In: Eighth International Symposium on Biomedical and
Clinical Aspects of Coenzyme Q (1994) Littarru G.P.,
Battino M. , Folkers K. (Eds) The Molecular Aspects of
Medicine, Vol. 15 (Supplement), pp S287-S294.
Pihko H., Saarinen U., and Paetau A. (1989) Wernicke
encephalopathy - a preventable cause of death: Report of 2
children with malignant disease. Pediatric Neurology vol. 5
no. 4, pp 237-242.
Hansen I.L. (1976) Bioenergetics in clinical medicine.
Gingival leucocytic deficiencies of coenzyme Q10 in patients
with periodontal disease. In: Research Communications in
Chemical Pathology and Pharmacology, vol. 14, no. 4,
pp 729-738.
Iwamoto Y., Watanabe T., Okamoto H., Ohata N., Folkers K.
Clinical effect of coenzyme Q10 on periodontal disease. In:
Folkers, K., Yamamura, Y., (eds) Biomedical and Clinical
Aspects of Coenzyme Q10, (1981) vol. 3, Elsevier,
Amsterdam, pp 109-119.
Folkers K., Langsjoen P. H., et al. (1988) Biochemical
deficiencies of coenzyme Q10 in HIV-infection and the
exploratory treatment. Biochemical and Biophysical
Research Communications vol. 153, no. 2, pp 888-896.
Langsjoen P. H., Langsjoen P. H., Folkers K., Richardson P.
Treatment of patients with human immunodeficiency virus
infection with coenzyme Q10. In: Folkers K., Littarru G.P.,
and Yamagami, T., (eds) Biomedical and Clinical Aspects of
Coenzyme Q, (1991) vol. 6, pp 409-415.
Cortes E.P, Mohinder G., Patel M., Mundia A., and Folkers
K. Study of Administration of coenzyme Q10 to Adriamycin
treated cancer patients. In:Biomedical and Clinical Aspects
of Coenzyme Q (1977). Folkers K., Yamamura Y. (eds)
Elsevier, Amsterdam, pp 267-273.
Combs A.B., Faria D.T., Leslie S.W., and Bonner H.W.
(1981) Effect of coenzyme Q10 on Adriamycin induced
changes in myocardial calcium. In: Biomedical and Clinical
Aspects of Coenzyme Q, vol. 3 Folkers, K., Yamamura Y.,
(eds) Elsevier, Amsterdam, pp 137-144.
Judy W.V. Hall J., H., Dugan W., Toth P.D., and Folkers K.
Coenzyme Q10 reduction of Adriamycin toxicity. In:
Biomedical and Clinical Aspects of Coenzyme Q (1983),
vol. 4 Folkers K., Yamamura Y., (eds) Elsevier, Amsterdam,
pp 231-241.
Lockwood K., Moesgaard S., Yamamoto T., Folkers K.
Progress on therapy of breast cancer with vitamin Q10 and
the regression of metastases. Biochem Biophys Res Commun
1995 Jul 6;212(1):172-7.
Lockwood K., Moesgaard S., Hanioka T., Folkers K.
Apparent partial remission of breast cancer in 'high risk'
patients supplemented with nutritional antioxidants, essential
fatty acids and coenzyme Q10. Mol Aspects Med 1994;15
Suppl:s231-40.
Lockwood K., Moesgaard S., Folkers K. Partial and
complete regression of breast cancer in patients in relation to
dosage of coenzyme Q10. Biochem Biophys Res Commun
1994 Mar 30;199(3):1504-8.
Folkers K., Brown R., Judy W.V., and Morita M. (1993)
Survival of cancer patients on therapy with coenzyme Q10.
Biochem. Biophys. Res. Comm., Ms. No. G-8658.
Mellstedt H., Osterborg A., Nylander M., Morita M., and
Folkers K. A deficiency of coenzyme Q10 (CoQ10) in
conventional cancer therapy and blood levels of CoQ10 in
cancer patients in Sweden. In: Eighth International
Symposium on Biomedical and Clinical Aspects of
Coenzyme Q (1994) The Molecular Aspects of Medicine, in
print.
Bowry V.W., Mohr D., Cleary J., Stocker R. (1995)
Prevention of tocopherol-mediated peroxidation in
ubiquinol-10-free human low density lipoprotein. J Biol
Chem 1995 Mar 17;270(11):5756-63.
Ingold K.U., Bowry V.W., Stocker R., Walling C. (1993)
Autoxidation of lipids and antioxidation by alpha-tocopherol
and ubiquinol in homogeneous solution and in aqueous
dispersions of lipids: unrecognized consequences of lipid
particle size as exemplified by oxidation of human low
density lipoprotein. Proc Natl Acad Sci U S A 1993 Jan
1;90(1):45-9.
Sun I.L., Sun E.E., Crane F.L., Morre, V.J., Lindgren A., and
Low H. Requirement for coenzyme Q in plasma membrane
electron transport. In: Proc. Nat. Acad. Sci. U SA 89,
11126-11130 (1992).
Linnane A.W., Zhang C., Baumer A., Nagley P. (1992)
Mitochondrial DNA mutation and the aging process:
bioenergy and pharmacological intervention. Mutation
Research 275, pp. 195-208.
Martinius R.D., Linnane A.W., Nagley P. (1993) Growth of
human namalwa cells lacking oxidative phosphorylation can
be sustained by redox compounds potassium ferricyanide or
coenzyme Q10 putatively acting through the plasma
membrane oxidase. In: Biochem. Mol. Biol. Internat. 31,
997-1005.
Lawin A., Martinius R.D., McMullen G., Nagley P., Vaillant
F., Wolvetang E. J., Linnane A.W. The universality of
bioenergetic disease: The role of mitochondrial DNA
mutation and the putative inter-relationship between
mitochondria and plasma membrane NADH oxidases. In:
Eighth International Symposium on Biomedical and Clinical
Aspects of Coenzyme Q (1994) Littarru G.P., Battino M. ,
Folkers K. (Eds) The Molecular Aspects of Medicine, Vol.
15 (Supplement), pp S13-S27.
Baggio, E., Gandini, R., Plancher, A. C., Passeri, M., Carmosino, G.: Italian multicenter study on
the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure (interim analysis).
Clin. Investig. 71 (8 Suppl.): 145-149 (1993)
Braun, B., Clarkson, P., Freedson, P. et al.: The effect of coenzyme Q10 supplementation on exer-
cise performance, VO2max. and lipid peroxidation in trained cyclists. Int. J. Sport Nutr. 1 (1991), (in
Press)
Brouns, F.: Nutritional needs of athletes. John Wiley & Sons Ltd., Chichester (1993)
Demopoulous, H., Santomier, J., Seligman, M. et al.: Free radical pathology: Rationale and toxi-
cology of antioxidants and other supplements in sports medicine and exercise science. In Katch F.
(Ed.), Sport Health and Nutrition, Human Kinetics Publishers, Champaign, Illinois (1986)
Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE),
Schweizerische Gesellschaft für Ernährung (SGE), Schweizerische Vereinigung für Ernährung
(SVE): DACH Referenzwerte für die Nährstoffzufuhr. 1. Aufl., Umschau Braus GmbH, Verlagsge-
sellschaft, Frankfurt a. M. (2000)
Deutsche Gesellschaft für Ernährung: Empfehlungen für die Nährstoffzufuhr. 5. Überarbeitung.
Umschau Verlag. Frankfurt/Main (1991)
Folkers, K.: Heart failure is a dominant defiency of coenzyme Q10 and challenges for future clinical
research on CoQ10. Clin. Invest., 71: 51-54 (1993)
Forstmann, M.: Lebensmittel und Kosmetische Mittel mit Zweitnutzen. ZLR 19: 587-607 (1992)
Franz, G.: 10 Fragen in der Ernährungsdiskussion. Ernährungs-Umschau 41: 343 (1994)
Hallstroem, H.: Oskadlighetsbedoemning av coenzym Q10 (Beurteilung der Unschädlichkeit von
Coenzym Q10. Var Foeda (Sweden); ISSN 0042-2657 (1993); v. 45(6) p. 250-259
Kaikkonen, J., Kosonen, L., Nyyssönen, K., Porkkala-Sarataho, E., Salonen, R., Korpela, H., Salo-
nen, J. T.: Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate supplementation on
exercise-induced lipid peroxidation and muscular damage: A placebo-controlled double-blind study
in marathon runners. Free Rad. Res., Vol. 29, pp 85-92 (1998)
Kamei, M., Fujita, T., Kanbe, T. et al.: The distribution and content of ubichinone in foods. Internat.
J. Vit. Nutr. Res. 56, 57-63 (1986)
Karlsson, J., Diamant, B., Theorell, H., Folkers, K.: Ubichinone and tocopherol in plasma; means of
translocation or depot. Clin. Investig. 71: 84-91 (1993)
Koske, Dagmar: Vergleich von Ubichinon und „Pangamsäure“ als Antioxidantien in biochemischen
Modellreaktionen. Lincom Studien zur Biochemie 01, 1998; Lincom Europa, D-80995 München,
ISBN 3-89586-582-6
Laaksonen, R. et al.: Ubiquinone supplementation and exercise capacity in trained young and ol-
der men. European Journal of Applied Physiology, 72: 95-100 (1995)
Lampertico, M., Comis, S.: Italian multicenter study on the efficacy and safety of coenzyme Q10 as
adjuvant therapy in heart failure. Clinical Investigator 71(8 Suppl.): 129-133 (1993)
Lenaz, G., Fato, R., Castelluccio, C., Genova, M. L., Bovina, C., Estornell, E., Valls, V., Pallotti, F.,
Rarenti Castelli, G.: The function of coenzyme Q in mitochondria. Clin. Investig. 71: 66-70 (1993)
Malm, C. et al.: Supplementation with ubiquinone-10 causes cellular damage during intense exer-
cise. Acta Physiologica Scandinavica, 157: 511-512 (1996)
Overvad, K., Diamant, B., Holm, L., Holmer, G., Mortensen, S. A., Stender, S.: Coenzyme Q10 in
health and desease . Eur. J. Clin. Nutr. 53: 765/766 (1999)
Permanetter, B.: Coenzym Q10 und Herzkrankheit. DMW 118: 1866 (1993)
Permanetter, B.: Aktuelles Interview: Coenzym Q10. Ernährungsumschau 10: B47-B48 (1994)
Recommended Dietary Allowances: 10th Edition. National Research Council, National Academy
Press, Washington, D.C. (1989)
Reports of the Scientific Committee for Food (Thirty-first series). Nutrient and energy intakes for
the European Community. ECSC-EEC-EAEC, Brussels, Luxembourg (1993)
Roberts, J.: The effect of coenzyme Q10 on exercise performance. Med. Sci. Sports Exerc. 22: 87
(1990), (abstract)
SCF: Reports of the Scientific Committee for Food (Thirty-first series): Nutrient and energy intakes
for the European Community. ECSC-EEC-EAEC, Brussels (1993)
Schek, A.: Ernährungsbezogene Leistungsförderer versus leistungsbezogene Ernährung. 1. Nähr-
stoffsubstitution und Nahrungs-/Genussmittel. Ernährungs-Umschau 42: 243-249 (1995)
Stryer, L.: Biochemistry. Third Edition, W. H. Freeman and Company, New York (1988)
The Swedish Council on Technology Assessment in Health Care: Preventing desease with antioxi-
dants: 1-18 (1997)
Weber, C., Bysted, A., Holmer, G.: The coenzyme Q10 content of the average Danish diet. Inter-
nat. J. Vit. Nutr. Res., 67, 123-129 (1997)
Weber, C., Bysted, A., Holmer, G.: Intestinal absorption of coenzyme Q10 administered in a meal
or as capsules to healthy subjects. Nutrition Research, Vol. 17, 941-945 (1997)
Zuliani, U., Bonetti, A., Campana, M. et al.: The influence of ubiquinone (CoQ10) on the metabolic
response to work. J. Sports Med. Phys. Fitness, 29: 57-61 (1989)
|
